ASSESSMENT OF CARDIOVASCULAR AND RENAL OUTCOMES FOLLOWING DAPAGLIFLOZIN THERAPY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND CHRONIC KIDNEY DISEASE. (2026). Asian Journal of Medical Research and Health Sciences, 4(2), 1398-1403. https://doi.org/10.65605/a-jmrhs.2026.v04.i02.pp1398-1403